Sangamo Therapeutics, Inc. (SGMO)
0.16
0.00 (0.00%)
USD |
OTCM |
May 21, 11:24
Sangamo Therapeutics EPS Diluted (Quarterly) : -0.0796 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AVITA Medical, Inc. | -0.3474 |
| INmune Bio, Inc. | -0.2034 |
| Agenus, Inc. | 1.023 |
| Curis, Inc. | -1.250 |
| LadRx Corp. | -1.453 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.00M |
| Revenue (Quarterly) | 1.442M |
| Total Expenses (Quarterly) | 32.44M |
| Enterprise Value | 56.38M |
| Gross Profit Margin (Quarterly) | 39.18% |
| Profit Margin (Quarterly) | -2.15K% |
| Earnings Yield | -239.4% |
| Normalized Earnings Yield | -223.00 |